Compare UFG & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFG | SCNX |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 16.2M |
| IPO Year | 2024 | 2019 |
| Metric | UFG | SCNX |
|---|---|---|
| Price | $0.36 | $3.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 251.0K | 46.9K |
| Earning Date | 09-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,831,778.00 |
| Revenue This Year | $26.00 | $1,009.57 |
| Revenue Next Year | N/A | $259.51 |
| P/E Ratio | $211.08 | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $0.36 | $3.24 |
| 52 Week High | $1.56 | $106.25 |
| Indicator | UFG | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 46.93 |
| Support Level | N/A | N/A |
| Resistance Level | $1.02 | $11.68 |
| Average True Range (ATR) | 0.04 | 8.46 |
| MACD | -0.01 | -1.49 |
| Stochastic Oscillator | 11.84 | 0.09 |
Uni-Fuels Holdings Ltd is a service provider of marine fuel solutions. It operates on an integrated business model, serving customers through two operating models: sales of marine fuels solutions and brokerage (i.e., acting as an intermediary between marine fuels suppliers and customers for a commission). The various marine fuel products offered by the company include very low sulfur fuel oil, high sulfur fuel oil, marine gas oil, and bio marine fuel. Its customers are mainly shipping companies and other fuel suppliers operating in market sectors such as bulk, tanker, offshore, container, general cargo, tug and barge, car carrier, cruise, yacht, and dredging. Geographically, the company derives maximum revenue from Singapore, and the rest from Malaysia, Hong Kong, China, and other regions.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.